{
  "name" : "dacemirror.sci-hub.se_journal-article_faed0df12d44079fff65334ba19de9e3_cong2019.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Titel: Microenvironment Induced in Situ Self-Assembly of Polymer- Peptides Conjugates that Attack Solid Tumor Deeply Autoren:",
    "authors" : [ "Yong Cong", "Lei Ji", "Yu-Juan Gao", "Fu-Hua Liu", "Dong-Bing Cheng", "Zhiyuan Hu", "Zeng-Ying Qiao", "Hao Wang" ],
    "emails" : [ ],
    "sections" : null,
    "references" : [ ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "Nanoparticles preferentially target and accumulate in tumor due to the abnormality of tumor vasculature. However, unsatisfactory solid tumor penetration somewhat limits the therapeutic efficacy. Herein, by employing ‘in vivo self-assembly’ strategy, we have designed an acid-induced hydrophobicity-increasing polymer-peptide conjugates (PPCs) with narrow pH response range (from 7.4 to 6.5) under proper molecular concentration (around IC50 of PPCs), successfully realizing in-situ self-assembly process in tumor microenvironment for tumor-deeper drug delivery. A cytotoxic peptide KLAK, decorated by a pH-sensitive moiety cis-aconitic anhydride (CAA), and a cell-penetrating peptide TAT, are conjugated onto the poly(β-thioester)s backbones to gain PT-K-CAA that can penetrates deeply into solid tumor due to its small size as a single chain. During the penetration in vivo, CAA responses to the weak acid, leading to self-assembly of PPCs and the recovery of therapeutic activity. Therefore, deep-penetration ability for enhanced cancer therapy of peptide nanomaterials is provided by this in-vivo assembly strategy. Nanodrugs possess prolonged circulation time and passive targeting capability, which realize targeted cancer therapy and reduced side effect. But a few defects still limit their therapeutic efficiency, such as tumor penetrability. Cancer cells deeplylocated in a solid tumor may escape from the clearance of nanodrugs, resulting in inefficient tumor treatment. The nanodrugs with small size contribute to high penetrability , but their accumulation or internalization are reduced. 8a, 9] Therefore, it is of great significance to achieve high penetration, accumulation and internalization at the same time. “In vivo self-assembly” strategy, attracting tremendous attention in recent years, may raise twilight upon tramping over the challenge. Xu et al have developed nanofibers based on the enzyme-instructed self-assembly (EISA) to target cancer cells, overcome multidrug resistance, or induce cell death selectively. However, limited reports confirm its feasibility in vivo. Polymer-peptide conjugates (PPCs), with long circulation time and good biocompatibility, may provide new direction in deep tumor treatment when combined with the in vivo selfassembly strategy. Scheme 1. (A) The hydrolysis process of the PT-K-CAA which leads to its selfassembly. (B) Schematic illustrations of the penetration process of PT-K-CAA in the tumor microenvironment. In tumor microenvironment, numerous drug release systems have been reported. The reverse approach, in which mildly acidic pH triggers assembly of polymers, has been rarely reported to the best of our knowledge. Herein, a microenvironment pHtriggered self-assembly strategy is first utilized to improve the solid tumor penetration and anticancer activity (Scheme 1). Two kinds of peptides, a cytotoxic peptide KLAK (sequence: CGGGKLAKLAKKLAKLAK) decorated by a pH-sensitive moiety, cis-aconitic anhydride (CAA), and a cell-penetrating peptide TAT (sequence: CYGRKKRRQRRR), are coupled to the poly(βthioester)s backbones to gain PT-K-CAA. The exposed carboxyl groups of CAA can increase the hydrophilicity of PT-K-CAA, which penetrates deeply into a solid tumor as a single chain with small size. Once reaching the microenvironment in tumor, the hydrolysis of CAA causes the hydrophobicity increase of PPCs and resultant self-assembly, forming nanoparticles around 100 nm. The increased size contributes to the high internalization efficiency, causing the improved therapeutic activity of PPCs. This on-site self-assembly strategy achieves a higher penetrability and therapeutic efficacy compared to the pre-assembled [a] Y. Cong , L. Ji , Y.-J. Gao, F.H. Liu, Dr. D.-B. Dong, Prof. Z. Hu, Prof. Z.-Y. Qiao, Prof. H. Wang CAS Center for Excellence in Nanoscience CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety National Center for Nanoscience and Technology (NCNST) No. 11 Beiyitiao, Zhongguancun, Beijing 100190, China E-mail: qiaozy@nanoctr.cn or wanghao@nanoctr.cn [b] Y. Cong, Prof. Z. Hu CAS Key Laboratory of Standardization and Measurement for Nanotechnology. Sino-Danish College University of Chinese Academy of Sciences, Beijing 100049 E-mail: huzy@nanoctr.cn; [c] Pro. Z. Hu Center for Neuroscience Research School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350108, Fujian Province, China [] These authors contributed equally to this work Supporting information for this article is given via a link at the end of the document. 10.1002/ange.201900135 A cc ep te d M an us cr ip t Angewandte Chemie This article is protected by copyright. All rights reserved.",
    "creator" : "pdftk 2.02 - www.pdftk.com"
  }
}